AR241222A1 - Procedimiento para elaborar nuevos acidos 3-amino- (1) benzazepin-2-alcanoicos y sus sales. - Google Patents

Procedimiento para elaborar nuevos acidos 3-amino- (1) benzazepin-2-alcanoicos y sus sales.

Info

Publication number
AR241222A1
AR241222A1 AR84295865A AR29586584A AR241222A1 AR 241222 A1 AR241222 A1 AR 241222A1 AR 84295865 A AR84295865 A AR 84295865A AR 29586584 A AR29586584 A AR 29586584A AR 241222 A1 AR241222 A1 AR 241222A1
Authority
AR
Argentina
Prior art keywords
benzazepin
ones
compounds
preparation
pharmaceutical preparations
Prior art date
Application number
AR84295865A
Other languages
English (en)
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Application granted granted Critical
Publication of AR241222A1 publication Critical patent/AR241222A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

PROCEDIMIENTO PARA ELABORAR NUEVOS ACIDOS 3-AMINO-(1)BENZAZEPIN-2-ONA-1- ALCANOICOS DE LA FORMULA I, DONDE R6 Y R7 SON OH ALCOXI O FENILALCOXI; R1 ES H, ALQUILO O FENILALQUILO; R2 ES H O ALQUILO YY R3 ES H O 7-HALOGENO, SUS ESTEREOISOMEROS Y SALES. UN COMPUESTO DE LA FORMULA II, DONDE R1 A R3 TIENEN LOS VALORES YA DADOS R'O O R''O UNO ES CIANO Y EL OTRO ES CIANO O - COR7 O COR6 R7 Y R6 YADEFINIDOS EL O LOS GRUPOS CIANO, MEDIANTE TRATAMIENTO CON ACIDOS FUERTES, O CON BASES FUERTES, SE CONVIERTEN EN EL O LOS GRUPOS COR6 O COR7.
AR84295865A 1981-08-11 1984-02-28 Procedimiento para elaborar nuevos acidos 3-amino- (1) benzazepin-2-alcanoicos y sus sales. AR241222A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29190781A 1981-08-11 1981-08-11
US31986381A 1981-11-09 1981-11-09

Publications (1)

Publication Number Publication Date
AR241222A1 true AR241222A1 (es) 1992-02-28

Family

ID=26967047

Family Applications (3)

Application Number Title Priority Date Filing Date
AR290295A AR240806A1 (es) 1981-08-11 1982-08-11 Procedimiento para la elaboracion de acidos 3-amino-(1)benzazepin- 2-ona-1-alcanoicos y sus sales.
AR84295865A AR241222A1 (es) 1981-08-11 1984-02-28 Procedimiento para elaborar nuevos acidos 3-amino- (1) benzazepin-2-alcanoicos y sus sales.
AR295866A AR240807A1 (es) 1981-08-11 1984-02-28 Procedimiento para obtener derivados de benzazepin-2-ona y sus sales

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR290295A AR240806A1 (es) 1981-08-11 1982-08-11 Procedimiento para la elaboracion de acidos 3-amino-(1)benzazepin- 2-ona-1-alcanoicos y sus sales.

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR295866A AR240807A1 (es) 1981-08-11 1984-02-28 Procedimiento para obtener derivados de benzazepin-2-ona y sus sales

Country Status (22)

Country Link
EP (1) EP0072352B1 (es)
KR (3) KR890003425B1 (es)
AR (3) AR240806A1 (es)
AT (1) ATE18397T1 (es)
AU (1) AU561395B2 (es)
CA (1) CA1196636A (es)
CY (1) CY1403A (es)
DD (1) DD202546A5 (es)
DE (1) DE3269625D1 (es)
DK (1) DK157881C (es)
ES (6) ES8502974A1 (es)
FI (1) FI76074C (es)
GB (1) GB2103614B (es)
GR (1) GR77256B (es)
HK (1) HK93387A (es)
HU (1) HU189628B (es)
IE (1) IE53668B1 (es)
IL (1) IL66501A (es)
NL (1) NL930112I2 (es)
NO (1) NO161558C (es)
NZ (1) NZ201555A (es)
PT (1) PT75395B (es)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3242599A1 (de) * 1982-11-18 1984-05-24 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel
US4473575A (en) * 1982-07-19 1984-09-25 Ciba-Geigy Corporation 3-Amino-(1)-benzazepin-2-one-1-alkanoic acids
DE3373469D1 (en) * 1982-09-30 1987-10-15 Merck & Co Inc 1-n-alkylcarboxy-benzofused lactams useful as antihypertensive agents
US4575503A (en) * 1983-02-10 1986-03-11 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
US4564612A (en) * 1983-04-22 1986-01-14 Takeda Chemical Industries, Ltd. Condensed, seven-membered ring compounds and their use
JPS608284A (ja) * 1983-06-29 1985-01-17 Mitsui Toatsu Chem Inc ベンゾチアゼピン誘導体およびその製造法
US4539150A (en) * 1983-06-29 1985-09-03 Mitsui Toatsu Chemicals, Inc. Benzothiazepine derivatives and their methods of preparation
IL72523A (en) * 1983-08-12 1988-06-30 Takeda Chemical Industries Ltd 3-amino-4-oxo-2,3,4,5-tetrahydro-1,5-benzoxazepine derivatives,their production and pharmaceutical compositions containing them
AU570710B2 (en) * 1983-08-12 1988-03-24 Takeda Chemical Industries Ltd. 4-oxo-2, 3, 4, 5-tetrahydro-1, 5-benzoxazepine derivatives
US4638000A (en) * 1983-08-12 1987-01-20 Takeda Chemical Industries, Ltd. Condensed seven-membered ring compounds, their production and use
DE3586445T2 (de) * 1984-06-26 1993-01-14 Merck & Co Inc Kondensierte benzo-laktam-verbindungen und deren pharmazeutische zusammensetzungen.
CA1266647A (en) * 1984-06-26 1990-03-13 William H. Parsons Benzofused lactams useful as antihypertensive agents and as cholecystokinin antagonists
EP0166357A3 (en) * 1984-06-26 1988-10-26 Merck & Co. Inc. Benzofused lactams and pharmaceutical compositions containing them
US4785089A (en) * 1985-06-13 1988-11-15 Ciba-Geigy Corporation Novel sulfonic acid esters and their preparation
DE3704661A1 (de) * 1987-02-14 1988-08-25 Hoechst Ag Annelierte azepinon- und azocinon-derivate, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung, sowie zwischenprodukte bei ihrer herstellung
EP0322779A3 (en) * 1987-12-29 1991-05-08 Yoshitomi Pharmaceutical Industries, Ltd. Benzolactam compounds and pharmaceutical uses thereof
TW197945B (es) * 1990-11-27 1993-01-11 Hoechst Ag
GB9100028D0 (en) * 1991-01-02 1991-02-20 Ici Plc Compounds
GB9212308D0 (en) * 1992-06-10 1992-07-22 Ici Plc Therapeutic compositions
US5504080A (en) * 1992-10-28 1996-04-02 Bristol-Myers Squibb Co. Benzo-fused lactams
EP0673371A1 (de) * 1992-12-11 1995-09-27 Novartis AG Benzazepinon-derivate
GB9310075D0 (en) * 1993-05-17 1993-06-30 Fujisawa Pharmaceutical Co New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
GB9311948D0 (en) * 1993-06-10 1993-07-28 Zeneca Ltd Substituted nitrogen heterocycles
US5801168A (en) * 1994-06-09 1998-09-01 Zeneca Limited Substituted nitrogen heterocycles
US5597922A (en) * 1994-07-29 1997-01-28 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon Glycine receptor antagonist pharmacophore
EP1229913A4 (en) * 1999-11-18 2005-01-19 Antexpharma Inc SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
JP4508528B2 (ja) 2000-12-27 2010-07-21 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング α−アミノ置換カルボン酸アミドの製造方法
WO2002076375A2 (en) 2001-03-27 2002-10-03 Ranbaxy Laboratories Limited Process for the preparation of benazepril
EP1443919A4 (en) 2001-11-16 2006-03-22 Bristol Myers Squibb Co DOUBLE INHIBITORS OF THE FATTY ACID BINDING PROTEIN OF THE ADIPOCYTES AND THE FATTY ACID BINDING PROTEIN OF KERATINOCYTES
AU2003250086A1 (en) * 2002-07-26 2004-02-23 Ciba Specialty Chemicals Holging Inc. Crystalline polymorphic and amorphous forms of benazepril hydrochloride
KR100710548B1 (ko) * 2002-12-26 2007-04-24 에스케이 주식회사 (ｓ)-3-아미노-2,3,4,5-테트라히드로-2-옥소-1Ｈ-1-벤자제핀-1-아세트산 및 이의 에스테르 화합물의 제조방법
US7459474B2 (en) 2003-06-11 2008-12-02 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
US8080579B2 (en) 2005-10-03 2011-12-20 The Regents Of The University Of Michigan Compositions and methods for treatment of inflammatory bowel disease
US7592461B2 (en) 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
WO2008057862A2 (en) 2006-11-01 2008-05-15 Bristol-Myers Squibb Company MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
EP2099767A1 (en) 2006-11-01 2009-09-16 Brystol-Myers Squibb Company Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US7828840B2 (en) 2007-11-15 2010-11-09 Med Institute, Inc. Medical devices and methods for local delivery of angiotensin II type 2 receptor antagonists
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CN102149710A (zh) 2008-06-24 2011-08-10 百时美施贵宝公司 糖皮质激素受体、AP-1和/或NF-κB 活性的环戊噻吩调节剂及其用途
EP3241839B1 (en) 2008-07-16 2019-09-04 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (ja) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド グアニル酸シクラーゼｃの超高純度アゴニスト、その作成および使用方法
US9593113B2 (en) 2013-08-22 2017-03-14 Bristol-Myers Squibb Company Imide and acylurea derivatives as modulators of the glucocorticoid receptor
CN113292495B (zh) * 2021-06-18 2022-09-13 迪嘉药业集团有限公司 一种 (s)-氨基化合物的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395150A (en) * 1965-02-26 1968-07-30 Squibb & Sons Inc Benzothiazepine carboxamides and derivatives thereof
GB1305278A (es) * 1970-03-12 1973-01-31

Also Published As

Publication number Publication date
ES526888A0 (es) 1985-04-16
HK93387A (en) 1987-12-18
NL930112I2 (nl) 1996-11-01
IL66501A0 (en) 1982-12-31
AR240806A2 (es) 1991-02-28
KR890003425B1 (ko) 1989-09-20
IE821929L (en) 1983-02-11
AU561395B2 (en) 1987-05-07
AU8701482A (en) 1983-05-12
GB2103614A (en) 1983-02-23
PT75395B (en) 1985-11-15
FI76074C (fi) 1988-09-09
NO161558B (no) 1989-05-22
ES514856A0 (es) 1985-02-01
ES8606285A1 (es) 1986-04-16
DK157881B (da) 1990-02-26
ES8502974A1 (es) 1985-02-01
CY1403A (en) 1987-12-18
FI76074B (fi) 1988-05-31
ES530658A0 (es) 1985-12-01
DK157881C (da) 1990-07-23
KR900001190B1 (ko) 1990-02-28
CA1196636A (en) 1985-11-12
ES526887A0 (es) 1986-04-16
ATE18397T1 (de) 1986-03-15
ES8601142A1 (es) 1985-11-01
NO822722L (no) 1983-02-14
ES8602682A1 (es) 1985-12-01
HU189628B (en) 1986-07-28
PT75395A (en) 1982-09-01
AR240807A1 (es) 1991-02-28
IL66501A (en) 1987-10-20
FI822770L (fi) 1983-02-12
IE53668B1 (en) 1989-01-04
DK358682A (da) 1983-02-12
EP0072352A1 (de) 1983-02-16
DE3269625D1 (en) 1986-04-10
GR77256B (es) 1984-09-11
KR900001191B1 (ko) 1990-02-28
ES526889A0 (es) 1986-02-01
NL930112I1 (nl) 1993-10-18
KR840001139A (ko) 1984-03-28
GB2103614B (en) 1984-11-21
EP0072352B1 (de) 1986-03-05
AR240806A1 (es) 1991-02-28
DD202546A5 (de) 1983-09-21
FI822770A0 (fi) 1982-08-09
ES8604523A1 (es) 1986-02-01
ES8504728A1 (es) 1985-04-16
AR240807A2 (es) 1991-02-28
NZ201555A (en) 1986-06-11
ES526886A0 (es) 1985-11-01
NO161558C (no) 1989-08-30

Similar Documents

Publication Publication Date Title
AR241222A1 (es) Procedimiento para elaborar nuevos acidos 3-amino- (1) benzazepin-2-alcanoicos y sus sales.
GB1069343A (en) Propanolamine derivatives
ES8703881A1 (es) Procedimiento para la fabricacion de derivados del acido &- (oxo-2 hexahidro-2,4,5,6,7,7a tieno (3,2-c)piridil-5) fenil acetico
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
AR241474A1 (es) Preparacion de derivados de acido 3-aciltriciclo ¡5.2.1.0(2.6)¿-3-azadecan-4-carboxilico utiles como inhibidores de la enzima convertidora en angiotensina.
ATE90107T1 (de) Peptide mit collagenase hemmender wirkung.
ATE21699T1 (de) Verfahren zur herstellung von 2-penemverbindungen.
ES503768A0 (es) Procedimiento de preparacion de derivados de 1-fenil-1-hi- droxi-etilamina
NO167088C (no) Nye 5-alkoxy-2,4 diaminoalkylbenzener saavel som haarfarvemiddel med 5-alkoxy-2,4-diamino-alkylbenzen.
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
HU903397D0 (en) Process for the production of new sulfonamides from benzocyclic- or benzo-heterocyclic acids, and medical prepartions containing them
IE872588L (en) Compounds
ATE51618T1 (de) Imidazolderivate, verfahren zu deren herstellung, deren anwendung und pharmazeutische zusammenstellungen.
FR2355796A1 (fr) Procede de preparation de fluorures d'acides perfluoro-alcoxy-propioniques
ES478871A1 (es) Un procedimiento de preparacion de 2,6-dialcoxibenzamidas.
SE7411243L (es)
DE3583261D1 (de) 2-hydroxy-3-aryloxypropyl oder 2-hydroxy-2-benzofuranylethyl tertiaeres amin mit antihyperglycemischer und/oder antiobesitaets-wirkung.
ES8106516A1 (es) Procedimiento de preparacion de nuevos derivados halovinca- monas y de sus sales de adicion acidas farmaceuticamente aceptables e isomeros opticamente activos de los mismos
ES2059348T3 (es) Composicion farmaceutica para el tratamiento de cataratas.
DE3787844D1 (de) Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
ES8300094A1 (es) "un procedimiento para preparar derivados de halofenil-piridil-alilamina".
ES552782A0 (es) Un procedimiento para preparar un compuesto de n-fenil-trans-4-guanidincometilciclohexanocarboxamida.
GB1497161A (en) Naphthyl derivatives
HUT43598A (en) Process for production of derivatives of new 4-hidroxiquinoline carbonic acid and medical compound containing thereof
ES556048A0 (es) Un procedimiento para la preparacion de un derivado de tiazolidina.